| Financial Year |
March 31 2023 |
| Monetary Funds |
922,469,572.89 |
| Held-for-trading Financial Assets |
125,528,819.18 |
| Notes Receivable |
39,301,314.34 |
| Accounts Receivable |
260,391,030.56 |
| Advances to Suppliers |
24,386,419.85 |
| Other Receivables |
4,178,705.94 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
315,483,984.74 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,270,499.99 |
| Other Current Assets |
1,127,729.63 |
| Total Current Assets |
1,800,443,905.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
44,000,000.00 |
| Long-term Equity Investment |
40,004,953.76 |
| Investment Properties |
264,000,446.31 |
| Fixed Assetes |
628,842,933.12 |
| Under-construction Projects |
62,801,803.84 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
64,417,167.85 |
| R&D expenses |
-- |
| Goodwill |
167,944,061.40 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
11,970,007.85 |
| Other Non-Current Assets |
944,871.00 |
| Sub-Total of Non-Current Assets |
1,291,511,128.48 |
| Total Assets |
3,091,955,034.11 |
| Short-Term Loans |
21,024,805.54 |
| Trading Financial liabilities |
-- |
| Notes Payable |
19,383,314.97 |
| Accounts Payable |
124,571,870.90 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
49,750,716.72 |
| Taxes Payable |
30,454,194.70 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
72,228,963.45 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
680,308.46 |
| Other Current Liabilities |
2,570,781.41 |
| Sub-Total of Current Liabilities |
345,081,289.00 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
11,878,549.48 |
| Other Non-Current Liabilities |
117,535.22 |
| Sub-Total of Non-Current Liabilities |
22,853,026.21 |
| Total Liabilities |
367,934,315.21 |
| Paid-In Capital(Or Share Stock) |
814,180,908.00 |
| Capital Surplus |
905,923,399.69 |
| Surplus Reserve |
100,975,384.39 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
664,670,651.48 |
| Minority Stockholder's Interest |
234,586,495.84 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,489,434,223.06 |
| Owner's Equity（Stockholder's Equity） |
2,724,020,718.90 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,091,955,034.11 |
